An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli

José M. Aguilar-Yáñez, Roberto Portillo-Lara, Gonzalo I. Mendoza-Ochoa et al. · 2010

Read An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli by José M. Aguilar-Yáñez, Roberto Portillo-Lara, Gonzalo I. Mendoza-Ochoa et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011694.txt.

Description

José Aguilar-Yáñez and co-authors made a flu vaccine component inside bacteria, in PLOS ONE in 2010. The 2009 H1N1 pandemic exposed the need for faster, higher-yield vaccine production. Growing virus in eggs or cell culture is slow, so the team tried a different factory: the common bacterium Escherichia coli.

They produced a fragment of the pandemic virus's hemagglutinin, its main surface protein, in the bacteria. A bacterial pipeline could be scaled up far faster than egg-based production during an emergency. The work supports a shortcut that might deliver pandemic vaccines while they can still do the most good.

Catalog record

CREATORJosé M. Aguilar-Yáñez, Roberto Portillo-Lara, Gonzalo I. Mendoza-Ochoa et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011694

Browse the full library · About the Tower of Babel